UNSPSC 51241502: Antazoline/naphazoline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP900. This VA Drug Class (OP900) classifies this compound as belonging to the group OPHTHALMICS, OTHER.

UNSPSC 51241502 Antazoline/naphazoline, a Commodity code, covers decongestant and antihistamine eye drops and topical products that state and local governments procure through cooperative purchasing vehicles and direct supply agreements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary recent issuing body under this code, seeking manufacturers of generic multi-source pharmaceuticals and over-the-counter products to supply participating state and local government facilities across multiple states including Oregon. Vendors must meet cGMP and Drug Supply Chain Security Act (DSCSA) compliance, maintain relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), and carry comprehensive insurance including $5 million commercial general liability, $2 million network security and privacy liability, and $2 million professional liability coverage.

MMCAP's RFP S1070000015802, posted January 20, 2026, with proposals due March 26, 2026, represents the primary activity in this commodity space. The alliance will award multiple contracts effective July 1, 2026, and will consider sole, dual, or multi-awards based on therapeutic considerations and member-specific needs. Evaluation will weight price competitiveness at 75 percent, with the remainder allocated to fixed pricing, administrative compliance, EDI capability, and willingness to accept a 3 percent administrative fee. Products must be available in the marketplace by May 15, 2026, with minimum one-year expiration dates and six-month shelf life from manufacture. The RFP does not disclose specific award values or budget ranges, but vendors should expect performance penalties ranging from $200 to $1,500 per violation for late reporting, missed onboarding, or improper class-of-trade denials.